AP
Apnimed, Inc.
APMD · NASDAQ
$26.22 -8.75% (-$2.52)
1M +2.30%
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
Asset turnover N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Debt/Assets N/A
Stability
0 /100
Unstable Beta 0.00x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o APMD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kevin R. Lind
Employees
65
Headquarters
Cambridge